(SWK) Stanley Black & Decker - Overview
Stock: Hand Tools, Power Tools, Outdoor Products, Fasteners
| Risk 5d forecast | |
|---|---|
| Volatility | 37.0% |
| Relative Tail Risk | -12.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.10 |
| Alpha | -43.16 |
| Character TTM | |
|---|---|
| Beta | 1.777 |
| Beta Downside | 1.940 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.31% |
| CAGR/Max DD | 0.03 |
EPS (Earnings per Share)
Revenue
Description: SWK Stanley Black & Decker March 06, 2026
Stanley Black & Decker, Inc. manufactures and distributes hand tools, power tools, and outdoor equipment globally. The company operates in two primary segments: Tools & Outdoor and Industrial.
The Tools & Outdoor segment offers a wide range of products, including professional and household power tools, hand tools, and lawn and garden equipment. These products are sold under well-known brands such as DEWALT, CRAFTSMAN, and BLACK+DECKER. Distribution channels include retailers, third-party distributors, and direct sales. This segment operates within a consumer discretionary sector, which is sensitive to economic cycles.
The Industrial segment provides engineered fastening and assembly solutions. Its products, including threaded fasteners and riveting systems, are sold to various industries such as automotive, manufacturing, and aerospace through a direct sales force and distributors. This segments business model often involves long-term contracts and specialized product development.
Founded in 1843, Stanley Black & Decker is headquartered in New Britain, Connecticut. For a deeper dive into SWKs financial health and market position, consider exploring its profile on ValueRay.
Headlines to watch out for
- Housing market slowdown impacts tool and outdoor product demand
- Raw material cost fluctuations compress manufacturing margins
- DIY consumer spending trends influence retail tool sales
- Industrial segment demand tied to automotive and aerospace production
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 401.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.21 > 1.0 |
| NWC/Revenue: 4.85% < 20% (prev 9.51%; Δ -4.66% < -1%) |
| CFO/TA 0.05 > 3% & CFO 971.2m > Net Income 401.9m |
| Net Debt (5.58b) to EBITDA (1.39b): 4.01 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (152.1m) vs 12m ago 0.28% < -2% |
| Gross Margin: 29.86% > 18% (prev 0.30%; Δ 2.96k % > 0.5%) |
| Asset Turnover: 70.22% > 50% (prev 70.33%; Δ -0.10% > 0%) |
| Interest Coverage Ratio: 1.89 > 6 (EBITDA TTM 1.39b / Interest Expense TTM 464.8m) |
Altman Z'' 2.48
| A: 0.03 (Total Current Assets 5.98b - Total Current Liabilities 5.25b) / Total Assets 21.24b |
| B: 0.39 (Retained Earnings 8.24b / Total Assets 21.24b) |
| C: 0.04 (EBIT TTM 880.2m / Avg Total Assets 21.55b) |
| D: 0.68 (Book Value of Equity 8.24b / Total Liabilities 12.19b) |
| Altman-Z'' Score: 2.48 = A |
Beneish M -3.21
| DSRI: 0.81 (Receivables 919.7m/1.15b, Revenue 15.13b/15.37b) |
| GMI: 1.00 (GM 29.86% / 29.76%) |
| AQI: 1.03 (AQ_t 0.63 / AQ_t-1 0.61) |
| SGI: 0.98 (Revenue 15.13b / 15.37b) |
| TATA: -0.03 (NI 401.9m - CFO 971.2m) / TA 21.24b) |
| Beneish M-Score: -3.21 (Cap -4..+1) = AA |
What is the price of SWK shares?
Over the past week, the price has changed by -6.55%, over one month by -17.64%, over three months by -2.59% and over the past year by -6.70%.
Is SWK a buy, sell or hold?
- StrongBuy: 5
- Buy: 1
- Hold: 12
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the SWK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 91.9 | 23.9% |
| Analysts Target Price | 91.9 | 23.9% |
SWK Fundamental Data Overview March 10, 2026
P/E Forward = 12.6582
P/S = 0.7798
P/B = 1.303
P/EG = 1.3904
Revenue TTM = 15.13b USD
EBIT TTM = 880.2m USD
EBITDA TTM = 1.39b USD
Long Term Debt = 4.70b USD (from longTermDebt, last quarter)
Short Term Debt = 1.16b USD (from shortTermDebt, last quarter)
Debt = 5.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.58b USD (from netDebt column, last quarter)
Enterprise Value = 17.38b USD (11.80b + Debt 5.86b - CCE 280.1m)
Interest Coverage Ratio = 1.89 (Ebit TTM 880.2m / Interest Expense TTM 464.8m)
EV/FCF = 25.27x (Enterprise Value 17.38b / FCF TTM 687.9m)
FCF Yield = 3.96% (FCF TTM 687.9m / Enterprise Value 17.38b)
FCF Margin = 4.55% (FCF TTM 687.9m / Revenue TTM 15.13b)
Net Margin = 2.66% (Net Income TTM 401.9m / Revenue TTM 15.13b)
Gross Margin = 29.86% ((Revenue TTM 15.13b - Cost of Revenue TTM 10.61b) / Revenue TTM)
Gross Margin QoQ = 33.16% (prev 30.65%)
Tobins Q-Ratio = 0.82 (Enterprise Value 17.38b / Total Assets 21.24b)
Interest Expense / Debt = 1.39% (Interest Expense 81.4m / Debt 5.86b)
Taxrate = 30.61% (69.8m / 228.0m)
NOPAT = 610.7m (EBIT 880.2m * (1 - 30.61%))
Current Ratio = 1.14 (Total Current Assets 5.98b / Total Current Liabilities 5.25b)
Debt / Equity = 0.65 (Debt 5.86b / totalStockholderEquity, last quarter 9.05b)
Debt / EBITDA = 4.01 (Net Debt 5.58b / EBITDA 1.39b)
Debt / FCF = 8.12 (Net Debt 5.58b / FCF TTM 687.9m)
Total Stockholder Equity = 8.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.87% (Net Income 401.9m / Total Assets 21.24b)
RoE = 4.47% (Net Income TTM 401.9m / Total Stockholder Equity 8.98b)
RoCE = 6.43% (EBIT 880.2m / Capital Employed (Equity 8.98b + L.T.Debt 4.70b))
RoIC = 3.95% (NOPAT 610.7m / Invested Capital 15.46b)
WACC = 8.64% (E(11.80b)/V(17.66b) * Re(12.46%) + D(5.86b)/V(17.66b) * Rd(1.39%) * (1-Tc(0.31)))
Discount Rate = 12.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.73%
[DCF] Terminal Value 67.35% ; FCFF base≈713.9m ; Y1≈468.7m ; Y5≈213.8m
[DCF] Fair Price = N/A (negative equity: EV 3.76b - Net Debt 5.58b = -1.83b; debt exceeds intrinsic value)
EPS Correlation: 24.31 | EPS CAGR: -10.08% | SUE: 0.67 | # QB: 0
Revenue Correlation: -81.27 | Revenue CAGR: -4.90% | SUE: -1.71 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.31 | Chg7d=-0.006 | Chg30d=+0.069 | Revisions Net=+2 | Analysts=11
EPS current Year (2026-12-31): EPS=5.37 | Chg7d=-0.001 | Chg30d=-0.248 | Revisions Net=-11 | Growth EPS=+15.1% | Growth Revenue=+0.7%
EPS next Year (2027-12-31): EPS=6.35 | Chg7d=-0.013 | Chg30d=-0.296 | Revisions Net=-9 | Growth EPS=+18.1% | Growth Revenue=+2.3%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.0% (Discount Rate 12.5% - Earnings Yield 3.5%)
[Growth] Growth Spread = -5.4% (Analyst 3.6% - Implied 9.0%)